Search results for "downstream"

Article Eliminating Residual Impurities Starts with a Strategic Plan
Numerous risk factors Residual impurities in biopharmaceutical processes can be traced back to raw materials or can form during upstream or downstream processing steps and upon storage. They can b…

Article Discover ÄKTA™ Pilot 600 with Martin
In this easy-to-use online learning series, our application specialist, Martin, gives detailed instructions on how to use the ÄKTA™ pilot 600 chromatography system. Create your user…

Article On-Demand Webinar: A Route to Deeper Process Understanding—Studying Resin Variability Using a Process Characterization Kit
Process robustness and success requires a thorough understanding of critical process parameters (CPPs), critical material attributes (CMAs), and sometimes interactions between these. Chromatography …

Article Approaches to Improve Efficiency in Biopharmaceutical Process Development
Click here to read the article >>   Time to experiment, time to clinic, and time to market are becoming even more important for developers and manufacturers of biopharmaceuticals. This a…

Article Capto™ High Productivity Resins
Capto™ chromatography resins give you increased productivity compared with Sepharose™ resins, through high binding capacity and high flow rates. Explore Capto™ resins now >>

Article Five Reasons for Outsourcing Chromatography Resin Lifetime Studies
Resin lifetime studies are a regulatory requirement for new drug application (NDA) filing. But are running these lengthy and repetitive studies the best use of your process development time? Discove…

Article Cytiva and GoSilico Agree to Co-market ChromX™ Mechanistic Modeling Software
The agreement facilitates the adoption of ChromX™ by scientists and users of resins, columns, and chromatography systems into their downstream process-development workflows to accelerate development…

Article Studying Resin Variability Using a Process Characterization Kit
Learn how Process Characterization Kits can be used to assess the potential impact of resin ligand density variability on product quality and process performance. Click here to read mor…

Article Factors Which Impact mAb Process Scale-Up
Thinking about your mAb scale-up processes early on can help avoid common pitfalls. Fast Trak™ scientists discuss factors that can influence a successful scale-up outcome.

Article A Continuous Confidence Boost
Continuous processing of monoclonal antibodies (mAb) could offer a number of advantages, but regulatory uncertainty and upfront investment remain sticking points. In this case study, Shanghai Henli…

Previous PageNext Page